GTR 114562847
Bids Are Invited For Aflibercept 40Mg/Ml - Intravitreal Solution And Others
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
114562847
Tendering Authority
Subscribe to view
Tender No
426/2026
Financer Name
Self-Funded
Work Title
Bids Are Invited For Aflibercept 40Mg/Ml - Intravitreal Solution And Others
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
16-07-2026
Closed
Work Detail
Aflibercept, Concentration:40 Mg/Ml, Pharmaceutical Form:Injectable Solution, Additional Characteristics:With Application System, Etanercept, Concentration:50 Mg/Ml, Pharmaceutical Form:Injectable Solution, Additional Characteristics:Prefilled Syringe, Fremanezumab, Concentration:150 Mg/Ml, Additional:Prefilled Syringe, Galcanezumab, Concentration:120 Mg/Ml, Pharmaceutical Form:Injectable, Human Immunoglobulin, Concentration:5 G, Pharmaceutical Form:Injectable
Key Value
Tender Value
1,505,485 - BRL
Tender Documents
Global Tender Document
1d509525-dfe1-4ac4-af46-0912bb7ffb9b.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.